STERIS PUBLIC LIMITED COMPANY
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Miscellaneous Personal Services, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about STERIS PUBLIC LIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2021-12-03 (pharmaceutical-technology.com)
The end of the inversion: will pharma leave Ireland after tax rises?
Ireland recently agreed to a 15% minimum tax rate, which could have implications for the pharmaceutical companies based there.
Read more
2020-10-09 (massdevice.com)
Steris to acquire Key Surgical for $850M
Steris (NYSE:STE) announced this week that it has agreed to buy Key Surgical, a manufacturer of disposable hospital and surgical products, for $850 million. Mentor, Ohio-based Steris said it expects that the acquisition will qualify for a tax benefit related to tax-deductible goodwill, effectively
Read more
2020-10-07 (modernhealthcare.com)
Steris to acquire Key Surgical for $850 million
Steris said acquisition of the U.S. hospital supplier will be made through a U.S. subsidiary and is expected to 'qualify for a tax benefit related to tax deductible goodwill' that will effectively reduce the purchase price to about $810 million.
Read more
2015-05-29 (nytimes.com)
Steris to Fight F.T.C. Move to Block Merger With Synergy Health (Published 2015)
The deal was one of the so-called tax inversions announced last year, in which an American company would reincorporate overseas to lower its tax rate.
Read more
2014-10-13 (telegraaf.nl)
Steris also wants to escape US tax burden | Financial | .nl
Once again, an American company active in the pharmaceutical market hopes to avoid strict tax laws in the United States through an acquisition. This time the hunter is called Steris and the British Synergy Health is the prey. The Americans have 1.9 billion dollars (1.5 billion euros) left for the British peer, it announced on Monday.
Read more
2014-10-13 (thestreet.com)
Steris Chases Tax Cuts with $1.9 Billion Synergy Health Purchase
The Ohio company defies a regulatory clampdown on inversions with the $1.9 billion deal.
Read more
2014-10-13 (ft.com)
Steris makes UK tax leap with $1.9bn Synergy inversion deal
US clampdown fails to prevent medical equipment maker from moving domicile
Read more
2014-10-13 (cityam.com)
Synergy Health share price soars as US rival Steris reignites tax inversion debate with $1.9bn deal - CityAM
US medical technology giant Steris yesterday announced it had bought British health services provider Synergy Health in a $1.9bn (£1.2bn) deal that re-opened the US tax inversion debate.
Read more
(massdevice.com)
Steris to buy UK's Synergy Health, tax savings eyed
The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Read more